FDA regulation related Press Releases
California Healthcare Institute Board Elects New Member
LA JOLLA, Calif.--(BUSINESS WIRE)-- CHI-California Healthcare Institute announced today the election of Rick Winningham, who serves as CEO of South San Francisco-based Theravance, to serve on the CHI Read more...
Research and Markets: Cost-Contained Regulatory Compliance: For the Pharmaceutical, Biologics, and Medical Device Industri
DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/852d5d/costcontained_reg) has announced the addition of John Wiley and Sons Ltd's new book "Cost-Contained Read more...
FDA Takes Actions on Darvon, Other Pain Medications Containing Propoxyphene
FDA Takes Actions on Darvon, Other Pain Medications Containing Propoxyphene The U.S. Food and Drug Administration is taking several actions to reduce the risk of overdose in patients using pain Read more...
FDA: Boxed Warning on Serious Mental Health Events to be Required for Chantix and Zyban
FDA: Boxed Warning on Serious Mental Health Events to be Required for Chantix and Zyban The U.S. Food and Drug Administration today announced that it is requiring manufacturers to put a Boxed Warning Read more...
Merck Statement in Response to FDA's June Communication with Updated Information on Leukotriene Inhibitors, Including Singulair
Merck Statement in Response to the FDA's June 12, 2009 Communication with Updated Information on Leukotriene Inhibitors, Including SINGULAIR® (montelukast sodium)
WHITEHOUSE STATION, Read more...
FDA Requests Labeling Change for Leukotriene Modifiers
FDA Requests Labeling Change for Leukotriene Modifiers The U.S. Food and Drug Administration today provided further updated safety information on a class of asthma drugs known as leukotriene Read more...
Agennix Receives Fast Track Designation From FDA for Talactoferrin in Combination With Sunitinib for Renal Cell Carcinoma a
Agennix Receives Fast Track Designation From FDA for Talactoferrin in Combination With Sunitinib for Renal Cell Carcinoma HOUSTON, May 19 /PRNewswire/ -- Agennix announced today that talactoferrin Read more...
Stem Cell Therapeutics Corp. Announces the FDA Has Lifted Its Clinical Hold on the Phase IIb Stroke Trial
Stem Cell Therapeutics Corp. Announces the FDA Has Lifted Its Clinical Hold on the Phase IIb Stroke Trial CALGARY, ALBERTA--(Marketwire - May 14, 2009) - Stem Cell Therapeutics Corp. ("SCT" or "the Read more...
FDA Requires Additional Labeling for Over-the-Counter Pain Relievers and Fever Reducers to Help Consumers Use Products Safely
FDA Requires Additional Labeling for Over-the-Counter Pain Relievers and Fever Reducers to Help Consumers Use Products Safely The Food and Drug Administration issued a final rule today that requires
Read more...FDA Authorizes Emergency Use of Influenza Medicines, Diagnostic Test in Response to Swine Flu Outbreak in Humans
FDA Authorizes Emergency Use of Influenza Medicines, Diagnostic Test in Response to Swine Flu Outbreak in Humans The U.S. Food and Drug Administration, in response to requests from the U.S. Centers
Read more...Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
